Related Experiment Video
Updated: May 28, 2026

06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Principle considerations for the use of transcriptomics in doping research
Elmo W I Neuberger1, Dirk A Moser, Perikles Simon
1Department of Sports Medicine, Rehabilitation and Disease Prevention, Johannes Gutenberg-University, Mainz, Germany.
Drug Testing and Analysis
|October 28, 2011
Summary
Screening the blood transcriptome for doping detection shows promise but faces challenges. Future technological advancements are needed to overcome biological and technical biases for reliable biomarker identification.
Area of Science:
- Genomics
- Molecular Biology
- Biomarker Discovery
Background:
- Microarray platforms enable genome-wide RNA expression analysis.
- Transcriptomics can identify gene expression patterns and cellular pathways.
- Doping substances may alter mRNA expression, detectable in blood.
Purpose of the Study:
- Critically review the potential and pitfalls of blood transcriptome screening for doping research.
- Assess transcriptomics as a tool for identifying gene expression signatures or biomarkers.
- Discuss the feasibility of using transcriptomics in doping controls.
Main Methods:
- Review of transcriptomic approaches and their application in doping research.
- Discussion of confounding factors affecting transcriptomic studies.
- Analysis of challenges in applying strict guidelines to field conditions.
Main Results:
- Transcriptomic approaches offer potential for biomarker discovery in various conditions.
- Significant biological and technical confounding factors impact transcriptomic data reliability.
- Field conditions for doping controls often prevent adherence to strict guidelines.
Conclusions:
- Current transcriptomic methods face limitations due to confounding factors in doping research.
- Standardized procedures are difficult to implement under typical doping control conditions.
- Further technological progress is required to develop robust and legally valid biomarkers.

